Groote Schuur Hospital

Cape Town, Western Cape 7925

4 studies enrolling now · 9 studies all time

What they study most

COVID 19, Focal Epilepsy, HIV Infections, Hip Fractures, Melanoma, Myocardial Injury, Relapsed or Refractory Multiple Myeloma, Seizures

Studies at this site

• A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) — Recruiting now
• A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy — Recruiting now
• HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial — Recruiting now
• A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery — Running, not enrolling
• Long-term Safety and Tolerability of BHV-7000 — Enrolling by invitation
• Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma — Running, not enrolling
• A Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of PGDM1400LS Alone and in Combination With VRC07-523LS and PGT121.414.LS in Healthy, HIV-uninfected Adult Participants — Completed
• CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION — Completed
• Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy — Completed